In consonance with our finding, a recent study by Kwon et al. reported that high GRP78 expression was an independent predictor of poor disease-free survival in EGFR-mutated lung adenocarcinoma, and it suggested the potential of the ER stress pathway as a prognostic biomarker and therapeutic target [46]. The gene discussed is EGFR; the disease is lung adenocarcinoma.